Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivomixx in Cirrhosis with SBP
NCT02552862Phase 3Withdrawn
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Visbiome in spontaneous bacterial peritonitis (SBP), Cirrhosis, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Planned start Sep 2016; status: withdrawn.
02
Drugs
Visbiome
03
Conditions
spontaneous bacterial peritonitis (SBP)Cirrhosis
Beyond the preview
Go deeper on NCT02552862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552862.